Lee Beom Hee, Cho Hee Yeon, Kang Hee Gyung, Ha Il Soo, Cheong Hae Il, Moon Kyung Chul, Lim In Seok, Choi Yong
Department of Pediatrics, Seoul National University Children's Hospital, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-744, South Korea.
Pediatr Nephrol. 2006 Nov;21(11):1707-15. doi: 10.1007/s00467-006-0246-8. Epub 2006 Sep 2.
Idiopathic membranous nephropathy (MN) is a rare cause of asymptomatic proteinuria (AP) or nephrotic syndrome (NS) in childhood. To improve our understanding of its clinical course, we retrospectively reviewed 19 cases of idiopathic MN seen in our hospital over a period of 28.5 years, i.e., from January 1977 to July 2005. Eight patients (39%) had AP and 11 (61%) presented with NS. All eight AP patients achieved remission, regardless of treatment modality. Oral corticosteroid was given to all 11 NS patients, but only three of them responded to corticosteroid. Of the eight steroid non-responders, three achieved remissions with the addition of cyclosporine, and the five who were not administered additional immunosuppressive drugs had persistent NS. At the latest evaluation, all six NS patients that achieved remission remained free of proteinuria and had a normal renal function. Moreover, two of the 5 steroid non-responders showed persistent nephrotic-range proteinuria but a stable renal function. The remaining three steroid non-responders progressed into chronic renal insufficiency, and this progression was preceded by renal vein thrombosis (RVT) in two of the three patients. Presentation with NS (P=0.045) and the development of RVT (P=0.010) were identified as poor prognostic factors.
特发性膜性肾病(MN)是儿童无症状蛋白尿(AP)或肾病综合征(NS)的罕见病因。为了增进我们对其临床病程的了解,我们回顾性分析了我院在1977年1月至2005年7月这28.5年间收治的19例特发性MN病例。8例患者(39%)表现为AP,11例(61%)表现为NS。所有8例AP患者均实现缓解,无论采用何种治疗方式。11例NS患者均接受了口服糖皮质激素治疗,但其中只有3例对糖皮质激素有反应。在8例对糖皮质激素无反应的患者中,3例加用环孢素后实现缓解,另外5例未加用其他免疫抑制药物的患者则持续患有NS。在最近一次评估时,所有6例实现缓解的NS患者均无蛋白尿,肾功能正常。此外,5例对糖皮质激素无反应的患者中有2例表现为持续性肾病范围蛋白尿,但肾功能稳定。其余3例对糖皮质激素无反应的患者进展为慢性肾功能不全,其中3例患者中有2例在进展之前发生了肾静脉血栓形成(RVT)。表现为NS(P = 0.045)和发生RVT(P = 0.010)被确定为不良预后因素。